Pharmadrug Inc.

CNSX:PHRX Stock Report

Market Cap: CA$1.6m

Pharmadrug Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Robert Steen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO

Robert Steen

1.4yrs

Tenure

Mr. Robert J. Steen is Chief Executive Officer of Pharmadrug Inc. from September 2023 and was its Chairman since September 2023 until February 2024 and is its Director since February 2024. He has helped fo...

Board Members

NamePositionTenureCompensationOwnership
Robert Steen
CEO & Director1.4yrsno datano data
Terrance Booth
Chairman of Advisory Board4.7yrsno datano data
Yelena Janjigian
Member of Advisory Boardno datano datano data
David Kideckel
Independent Chairman of the Board3.5yrsCA$206.30no data
Paul McClory
Independent Director8.2yrsCA$27.460.040%
CA$ 642.9
Steven Barker
Member of Advisory Board4yrsno datano data
Cindy Hutnik
Member of Scientific & Clinical Advisory Board3.2yrsno datano data
Jimo Borjigin
Member of Advisory Boardno datano datano data
Zalman Goldman
Director1.1yrsno datano data

3.5yrs

Average Tenure

66.5yo

Average Age

Experienced Board: PHRX's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 11:33
End of Day Share Price 2025/02/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharmadrug Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.